Search Results

Editorial [Hot topic: The Role of Pemetrexed in Lung Cancer (Guest Editors: Daoyuan Wang and Jianxing He)]

Authors: Wang, Daoyuan; He, Jianxing

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 1-1(1)

Publisher: Bentham Science Publishers

The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer

Authors: Konopa, Krzysztof; Jassem, Jacek

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 2-11(10)

Publisher: Bentham Science Publishers

Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

Authors: Giovannetti, Elisa; Honeywell, Richard; Hanauske, Axel R.; Tekle, Christina; Kuenen, Bart; Sigmond, Jennifer; Giaccone, Giuseppe; Peters, Godefridus J.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 12-28(17)

Publisher: Bentham Science Publishers

Role of Pemetrexed and Platinums Combination in Patients with Non- Small Cell Lung Cancer

Authors: Chen, Manyin; Shao, Wenlong; He, Jianxing; Wang, Daoyuan

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 29-36(8)

Publisher: Bentham Science Publishers

The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action

Authors: Joerger, M.; Omlin, A.; Cerny, T.; Fruh, M.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 37-47(11)

Publisher: Bentham Science Publishers

Predictive Markers for Haematological Toxicity of Pemetrexed

Authors: Kao, S. C.H.; Phan, V. H.; Clarke, S. J.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 48-57(10)

Publisher: Bentham Science Publishers

The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer

Author: Tucker, Steven

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 58-60(3)

Publisher: Bentham Science Publishers

The Role of Pemetrexed Combined with Gemcitabine for Non-Small-Cell Lung Cancer

Authors: Ngeow, Joanne; Toh, Chee-Keong

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 61-66(6)

Publisher: Bentham Science Publishers

The Role of Chemotherapy and Radiation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Authors: Wagner, Timothy D.; Yang, Gary Y.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 67-73(7)

Publisher: Bentham Science Publishers

The Role of Pemetrexed in Lung Adenocarcinoma, Mixed Subtype with Bronchioloalveolar Carcinoma Features

Authors: Duruisseaux, Michael; Cadranel, Jacques; Perol, Maurice; Arpin, Dominique

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 74-77(4)

Publisher: Bentham Science Publishers

Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer

Author: Vincent, Mark

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 78-84(7)

Publisher: Bentham Science Publishers

Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer

Authors: Li, Tianhong; Lara Jr., Primo N.; Mack, Philip C.; Perez-Soler, Roman; Gandara, David R.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 85-94(10)

Publisher: Bentham Science Publishers

In vitro and in vivo biological activity of PEDF against a range of tumors

Authors: Broadhead, Matthew L; Dass, Crispin R; Choong, Peter FM

Source: Expert Opinion on Therapeutic Targets, Volume 13, Number 12, December 2009 , pp. 1429-1438(10)

Publisher: Informa Healthcare

Editorial [Hot topic: Target Therapy of Bone Metastases and Tumours (Guest Editors: M. Caraglia and D. Santini)]

Authors: Caraglia, Michele; Santini, Daniele

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 789-790(2)

Publisher: Bentham Science Publishers

Anti-Tumour Effects of Bisphosphonates - What have we Learned from In Vivo Models?

Authors: Brown, H. K.; Holen, I.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 807-823(17)

Publisher: Bentham Science Publishers

Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials

Author: Gnant, M.

Source: Current Cancer Drug Targets, Volume 9, Number 7, November 2009 , pp. 824-833(10)

Publisher: Bentham Science Publishers

Geological controls on radon potential in Scotland

Authors: Scheib, C.; Appleton, J. D.; Miles, J. C. H.; Green, B. M. R.; Barlow, T. S.; Jones, D. G.

Source: Scottish Journal of Geology, Volume 45, Number 2, 1 October 2009 , pp. 147-160(14)

Publisher: Geological Society Publishing House

Expression of ERCC1 and class IIIβ tubulin for predicting effect of carboplatin/paclitaxel in patients with advanced inoperable non-small cell lung cancer

Authors: Ikeda, Satoshi; Takabe, Kazuhiko; Suzuki, Keiko

Source: Pathology International, Volume 59, Number 12, December 2009 , pp. 863-867(5)

Publisher: Blackwell Publishing

Contrasts in Alcohol-Related Mortality in Estonia: Education and Ethnicity

Authors: Rahu, Kaja; Prna, Kersti; Palo, Ene; Rahu, Mati

Source: Alcohol and Alcoholism, Volume 44, Number 5, 19 August 2009 , pp. 517-522(6)

Publisher: Oxford University Press

Calmodulin inhibition contributes to sensitize TRAIL-induced apoptosis in human lung cancer H1299 cells

Authors: Hwang, Mi-kyung; Min, Yong K.; Kim, Seong H.w.a.n.

Source: Biochemistry and Cell Biology, Volume 87, Number 6, 1 December 2009 , pp. 919-926(8)

Publisher: NRC Research Press